Trinity Capital Inc. reports developments as an alternative asset manager and specialty lender focused on private credit for growth-oriented companies. Its recurring news includes quarterly financial results, net investment income, NAV movement, new commitments, funded investments, repayments, exits, and portfolio activity across Sponsor Finance, Equipment Finance, Tech Lending, Asset Based Lending, and Life Sciences.
Company updates also cover secured loans, equipment financings, warrant and equity investments, sponsored investment funds, SBIC-related activity, and growth-capital facilities for portfolio companies in technology, life sciences, medical technology, energy infrastructure, and other innovation-driven markets.
Codexis (CDXS) entered into a $60 million senior secured term loan agreement with Trinity Capital to refinance its existing debt.
The initial $42.5 million drawdown funded repayment of the loan held by Innovatus Life Sciences Lending Fund I, which would have begun amortizing in March 2027. Codexis had $42.5 million in outstanding debt after closing. The new loan provides 48 months of interest-only payments, followed by a 12-month principal repayment period beginning November 2030. Codexis said the refinancing provides flexibility to advance its growth initiatives, including industrializing its ECO Synthesis platform for siRNA therapeutics manufacturing.
Trinity Capital (NYSE: TRIN) reported third-quarter 2026 net investment income of $49.9 million, up 34.9% from a year earlier. Income per basic share remained $0.52, while total investment income rose 30.2% to $98.4 million. Net assets from operations increased $46.9 million, versus $27.6 million a year earlier.
Net asset value per share rose to $13.61 from $13.47 at June 30. Trinity funded $614.1 million of investments and originated $880.5 million of commitments. Three portfolio companies had loans on non-accrual status, valued at approximately $17.2 million. Available liquidity was approximately $225.0 million, and net leverage was approximately 117%. Quarterly share sales raised $57.8 million net; subsequent sales raised $23.5 million net. On October 5, Trinity issued $350.0 million of 7.500% unsecured notes due 2032, partly to repay credit-facility debt. Regular fourth-quarter dividends total $0.51 per share.
Trinity Capital (NYSE: TRIN) announced a commitment of $20 million in growth capital to medical technology company ABM Respiratory Care.
ABM develops airway clearance and ventilation solutions for people with acute and chronic respiratory conditions. The financing is intended to support commercial expansion, a broader global market presence, and continued investment in product innovation, clinical research and connected respiratory care technologies. The announcement describes a capital commitment, rather than a completed disbursement.
ABM Respiratory Care secured a $20 million growth capital commitment from Trinity Capital (NYSE: TRIN) to support commercial expansion.
ABMRC plans to use the financing to strengthen its presence in existing and new markets and advance product innovation, clinical research and connected respiratory care technologies. Its BiWaze platform includes two FDA-cleared systems: BiWaze Clear for lower-airway clearance and BiWaze Cough to help patients with an ineffective cough clear secretions. The company is also advancing its Arc Connect digital health platform, designed to support patient engagement and therapy tracking.
Trinity Capital (NYSE: TRIN) originated $880 million in new commitments during the third quarter of 2026, bringing nine-month commitments to $2.0 billion. Quarterly commitments comprised $534 million in secured loans, $270 million in equipment financings and $76 million in equity investments.
Third-quarter gross investments funded totaled approximately $614 million: $378 million in secured loans, $159 million in equipment financings and $77 million in warrant and equity investments. Funding reached 15 new and 24 existing portfolio companies, plus multi-sector holdings. Repayments and exits generated approximately $495 million in gross proceeds.
For the first three quarters, gross investments funded totaled approximately $1.5 billion, while repayments and exits generated approximately $1.1 billion. Complete third-quarter results are scheduled for November 4, 2026.
Trinity Capital (NYSE: TRIN) will release its third-quarter 2026 financial results on November 4, 2026, and host an earnings call. Results will be released at 8:00 a.m. ET, followed by the call at 12:00 p.m. ET. A live webcast will be available on the investor relations website, with a website replay available for 90 days following the call.
Trinity Capital (NYSE: TRIN) has priced an underwritten public offering of $350.0 million in notes due 2032. The unsecured notes bear 7.50% annual interest, payable semiannually beginning January 15, 2027, and mature on January 15, 2032.
The company expects the offering to close on October 5, 2026, subject to customary closing conditions. Trinity intends to use net proceeds to pay down part of its outstanding KeyBank Credit Facility debt and for general corporate purposes. It may redeem the notes in whole or in part at any time at par, plus a make-whole premium, if applicable—a potential additional redemption payment.
Trinity Capital (TRIN) entered into a $50 million corporate debt facility with Wayflyer, a Dublin-based working capital provider for small businesses. The facility expands the pool of growth capital available to Wayflyer and supports rising demand for its funding products and investments in areas such as its AI capability, Intelligence.
For Trinity, the transaction extends its European lending programme run from its London office. Wayflyer has recently added a $1.5 billion forward flow arrangement with Fortress Investment Group and a $250 million credit facility with ATLAS SP Partners, bringing its total funding capacity to deploy up to $4.5 billion over 24 months. Trinity has deployed more than $6.2 billion across over 490 investments as of June 30, 2026.
Trinity Capital (TRIN) declared monthly cash dividends of $0.17 per share for October, November and December 2026.
The fourth-quarter 2026 distributions match the monthly rate paid during the first nine months of 2026, and shareholders have now received a consistent or increased dividend for seven consecutive years. For these dividends, the record dates are October 15, November 13, and December 11, 2026, with payment dates on October 30, November 30, and December 31, 2026, respectively.
The company targets regular dividends equal to about 90%–100% of taxable quarterly or annual income to maintain regulated investment company tax status and may also pay supplemental dividends or spill over excess taxable income into the following year.
Trinity Capital (NYSE: TRIN) announced an equipment financing commitment to LuxWall, a developer of Transparent Insulation based on vacuum insulation technology. According to Trinity Capital, the financing will support LuxWall’s manufacturing expansion to increase production capacity and scale deployment of its energy-efficient window solutions across global residential and commercial buildings.